Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana
Authors:
- 1 July 2007
- journal article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 28 (7) , 1067-1074
Abstract
To investigate the biotransformation of metoprolol, a β1-cardioselective adrenoceptor antagonist, by filamentous fungus, and to compare the parallels between microbial transformation and mammalian metabolism. Five strains of Cunninghamella (C elegans AS 3.156, C elegans AS 3.2028, C echinulata AS 3.2004, C blakesleeana AS 3.153 and AS 3.910) were screened for the ability to transform metoprolol. The metabolites of metoprolol produced by C blakesleeana AS 3.153 were separated and assayed by liquid chromatography-tandem mass spectrometry (LC/MSn). The major metabolites were isolated by semipreparative HPLC and the structures were identified by a combination of LC/MSn and nuclear magnetic resonance analysis. Metoprolol was transformed to 7 metabolites; 2 were identified as new metabolites and 5 were known metabolites in mammals. The microbial transformation of metoprolol was similar to the metabolism in mammals. The fungi belonging to Cunninghamella species could be used as complementary models for predicting in vivo metabolism and producing quantities of metabolite references for drugs like metoprolol.Keywords
This publication has 17 references indexed in Scilit:
- Analytical Tools and Approaches for Metabolite Identification in Early Drug DiscoveryPharmaceutical Research, 2006
- The effect of the corticosteroid hormone cortexolone on the metabolites produced during phenanthrene biotransformation in Cunninghamella elegansChemosphere, 2006
- Biotransformation of indomethacin by the fungus Cunninghamella blakesleeana1Acta Pharmacologica Sinica, 2006
- The expression of cytochrome P-450 and cytochrome P-450 reductase genes in the simultaneous transformation of corticosteroids and phenanthrene byCunninghamella elegansFEMS Microbiology Letters, 2006
- Introduction of Metoprolol Increases Plasma B-Type Cardiac Natriuretic Peptides in Mild, Stable Heart FailureCirculation, 2006
- STRUCTURAL ELUCIDATION OF HUMAN OXIDATIVE METABOLITES OF MURAGLITAZAR: USE OF MICROBIAL BIOREACTORS IN THE BIOSYNTHESIS OF METABOLITE STANDARDSDrug Metabolism and Disposition, 2006
- In vivo biotransformation of metoprolol in the horse and on-column esterification of the aminocarboxylic acid metabolite by alcohols during solid phase extraction using mixed mode columnsJournal of Pharmaceutical and Biomedical Analysis, 2006
- Biotransformation of pantoprazole by the fungusCunninghamella blakesleeanaXenobiotica, 2005
- Transformation of Verapamil byCunninghamella blakesleeanaApplied and Environmental Microbiology, 2004
- Atenolol inhibits the elimination of disopyramideEuropean Journal of Clinical Pharmacology, 1985